<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02558192</url>
  </required_header>
  <id_info>
    <org_study_id>IN001</org_study_id>
    <nct_id>NCT02558192</nct_id>
  </id_info>
  <brief_title>Administration of a Lactobacillus GG and Vitamins Containing Mixture is Effective in Preventing Nosocomial Infection in Children</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federico II University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federico II University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nosocomial infections are infections that occur from the time of 'entry in the hospital up to
      48h after discharge. In most developed countries, the incidence of nosocomial infections in
      children is between 5% and 44% with the predominance of respiratory infections and
      gastrointestinal infections. Nosocomial infections prolong the time of hospital stay, reduce
      the effectiveness of treatment, significantly increasing hospital costs. Current measures for
      prevention of nosocomial infections in pediatrics, such as vaccinations and compliance with
      sanitary regulations, are not fully effective. Therefore it is necessary a deepening of the
      possible methods of prevention, between which has been already tested the use of probiotics
      such as Lactobacillus GG. A recent RCCT, which provided for the administration of LGG against
      placebo, noted a significant reduction in the risk of gastrointestinal infections and
      respiratory infections in hospitalized children treated with LGG, compared with patients who
      received placebo. There are also evidence which demonstrate a potential role zinc in reducing
      the incidence of respiratory infections is that bowel. We thought, therefore, to perform a
      multicenter randomized controlled trial with the aim to evaluate the role of a complex
      containing LGG, vitamins and zinc in the prevention of nosocomial gastrointestinal and
      respiratory tract infections in pediatric wards.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Study the incidence of nosocomial gastrointestinal infection</measure>
    <time_frame>After 15 days of treatment</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Study the incidence of nosocomial URTI</measure>
    <time_frame>After 15 days of treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Days of hospitalization</measure>
    <time_frame>After 3 months from the enrollment</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The incidence of gastrointestinal and respiratory infection during the 3 month follow-up period</measure>
    <time_frame>After 3 months from the treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Nosocomial Infection</condition>
  <arm_group>
    <arm_group_label>Probiotics</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Vials containing 3 x 10^9 Colony Forming Units of LGG, vitamins ( B and C) and zinc</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Vials containing water, maltodextrin, magnesium stearate, potassium sorbate, sodium benzoate, citric acid, fructose, flavor.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lactobacillus Rhamnosus GG</intervention_name>
    <description>1 vials q12 for 15 days</description>
    <arm_group_label>Probiotics</arm_group_label>
    <other_name>LGG</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>PLACEBO</intervention_name>
    <description>1 vials q12 for 15 days</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Males and females between the ages of 3 months and 5 years

          -  Children admitted to a pediatric ward

        Exclusion Criteria:

          -  Children with chronic diseases of the respiratory , gastrointestinal , renal system;

          -  Children with malformations of the cardiovascular system ;

          -  Children with immune deficiencies ;

          -  Infants born preterm ( gestational age &lt; 37 weeks ) ;

          -  Children with congenital metabolic diseases ;

          -  Children Who received probiotics before enrollment ( up to 7 days before
             hospitalization)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Months</minimum_age>
    <maximum_age>5 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alfredo Guarino, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Univesità degli Studi di Napoli &quot;Federico II&quot;</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Naples &quot;Federico II&quot;</name>
      <address>
        <city>Naples</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Hojsak I, Abdović S, Szajewska H, Milosević M, Krznarić Z, Kolacek S. Lactobacillus GG in the prevention of nosocomial gastrointestinal and respiratory tract infections. Pediatrics. 2010 May;125(5):e1171-7. doi: 10.1542/peds.2009-2568. Epub 2010 Apr 19.</citation>
    <PMID>20403940</PMID>
  </reference>
  <reference>
    <citation>Guarner F, Bourdet-Sicard R, Brandtzaeg P, Gill HS, McGuirk P, van Eden W, Versalovic J, Weinstock JV, Rook GA. Mechanisms of disease: the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol. 2006 May;3(5):275-84. Review.</citation>
    <PMID>16673007</PMID>
  </reference>
  <reference>
    <citation>Packey CD, Sartor RB. Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases. J Intern Med. 2008 Jun;263(6):597-606. doi: 10.1111/j.1365-2796.2008.01962.x. Review.</citation>
    <PMID>18479259</PMID>
  </reference>
  <reference>
    <citation>Macpherson AJ, Harris NL. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol. 2004 Jun;4(6):478-85.</citation>
    <PMID>15173836</PMID>
  </reference>
  <reference>
    <citation>Mazmanian SK, Kasper DL. The love-hate relationship between bacterial polysaccharides and the host immune system. Nat Rev Immunol. 2006 Nov;6(11):849-58. Epub 2006 Oct 6. Review.</citation>
    <PMID>17024229</PMID>
  </reference>
  <reference>
    <citation>Brooks WA, Santosham M, Naheed A, Goswami D, Wahed MA, Diener-West M, Faruque AS, Black RE. Effect of weekly zinc supplements on incidence of pneumonia and diarrhoea in children younger than 2 years in an urban, low-income population in Bangladesh: randomised controlled trial. Lancet. 2005 Sep 17-23;366(9490):999-1004.</citation>
    <PMID>16168782</PMID>
  </reference>
  <reference>
    <citation>Sazawal S, Black RE, Bhan MK, Bhandari N, Sinha A, Jalla S. Zinc supplementation in young children with acute diarrhea in India. N Engl J Med. 1995 Sep 28;333(13):839-44.</citation>
    <PMID>7651474</PMID>
  </reference>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 13, 2015</study_first_submitted>
  <study_first_submitted_qc>September 22, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 23, 2015</study_first_posted>
  <last_update_submitted>September 22, 2015</last_update_submitted>
  <last_update_submitted_qc>September 22, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 23, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federico II University</investigator_affiliation>
    <investigator_full_name>Alfredo Guarino</investigator_full_name>
    <investigator_title>Full Professor of Pediatrics</investigator_title>
  </responsible_party>
  <keyword>LGG</keyword>
  <keyword>Probiotics</keyword>
  <keyword>nosocomial infection prevention</keyword>
  <keyword>pediatrics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Cross Infection</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

